| Tenofovir Disoproxil Fumarate | 2004/01/01 | English | 315 |
| Clinical Pharmacokinetics of Levetiracetam | 2004/01/01 | English | 312 |
| The Clinical Pharmacokinetics of Levofloxacin | 1997/02/01 | English | 309 |
| Clinical Pharmacokinetics of Docetaxel | 1999/01/01 | English | 308 |
| Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib | 2000/03/01 | English | 306 |
| The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients | 2011/02/01 | English | 297 |
| Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802 | 1999/01/01 | English | 295 |
| Clinical Pharmacokinetics of Cyclosporin | 1986/01/01 | English | 291 |
| How Important Are Gender Differences in Pharmacokinetics? | 2002/01/01 | English | 288 |
| Clinical Pharmacokinetics and Pharmacodynamics of Propofol | 2018/07/18 | English | 285 |
| Clinical Pharmacokinetics of Cyclophosphamide | 2005/01/01 | English | 279 |
| Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors | 2002/01/01 | English | 279 |
| Augmented Renal Clearance | 2010/01/01 | English | 273 |
| Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects | 2013/05/17 | English | 272 |
| Geographical/Interracial Differences in Polymorphic Drug Oxidation | 1995/09/01 | English | 272 |
| The Influence of Sex on Pharmacokinetics | 2003/01/01 | English | 271 |
| Clinical Pharmacokinetics of Quetiapine | 2001/01/01 | English | 268 |
| Clinical Pharmacokinetics of Doxorubicin | 1988/07/01 | English | 267 |
| Rivaroxaban | 2011/10/01 | English | 267 |
| Clinical Pharmacokinetics of Capecitabine | 2001/01/01 | English | 263 |
| The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to Outcome | 1995/02/01 | English | 262 |
| Clinical Pharmacokinetics of Rifampicin | 1978/01/01 | English | 261 |
| Clinical Pharmacokinetics of Fentanyl and its Newer Derivatives | 1983/01/01 | English | 255 |
| Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I | 2010/03/01 | English | 255 |
| Clinical Pharmacokinetics of Diclofenac | 1997/09/01 | English | 254 |
| Clinical Pharmacokinetics of Vancomycin | 1986/01/01 | English | 253 |
| Impact of Obesity on Drug Metabolism and Elimination in Adults and Children | 2012/05/01 | English | 252 |
| Guidelines on Paediatric Dosing on the Basis of Developmental Physiology and Pharmacokinetic Considerations | 2006/01/01 | English | 252 |
| Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children | 2006/01/01 | English | 252 |
| A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics | 2006/01/01 | English | 252 |